Earlier today, it was announced that Precigen’s PAPZIMEOS (formerly PRGN-2012) was FDA-approved for adults with RRP. Read why ...

The year began with fireworks, as Marvell delivered record revenue and earnings in Q1, propelled by AI’s insatiable appetite ...

Zillow stock is receiving a boost from rental growth. Here's what investors need to know about the real estate company's new ...